Muramyl dipeptide potentiates staphylococcal lipoteichoic acid induction of cyclooxygenase-2 expression in macrophages

Microbes and Infection

Volumn 16, Issue 2, 2014, Pages 153-160

  Ahn, Ki Bum ^a   Jeon, Jun Ho ^b   Baik, Jung Eun ^a   Park, Ok Jin ^a   Kang, Seok Seong ^a   Yun, Cheol Heui ^c   Park, Jong Hwan ^d   Han, Seung Hyun ^a  

^a BK 21 Plus   (South Korea)

^b Korea National Institute of Health   (South Korea)

^c Seoul National University   (South Korea)

^d Konyang University   (South Korea)

Author keywords

Cyclooxygenase 2; Lipoteichoic acid; Muramyl dipeptide; NOD2; Staphylococcus aureus; TLR2

Indexed keywords

CYCLOOXYGENASE-2; LIPOTEICHOIC ACID; MURAMYL DIPEPTIDE; NOD2; STAPHYLOCOCCUS AUREUS; TLR2;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; ANIMALS; CELLS, CULTURED; CYCLOOXYGENASE 2; HOST-PATHOGEN INTERACTIONS; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, KNOCKOUT; NOD2 SIGNALING ADAPTOR PROTEIN; STAPHYLOCOCCUS AUREUS; TEICHOIC ACIDS; TOLL-LIKE RECEPTOR 2;

EID: 84894980746     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2013.10.018     Document Type: Article

References (40)

1. Bonventre J.V., Nemenoff R. Renal tubular arachidonic acid metabolism. Kidney Int. 1991, 39:438-449.
2. Seibert K., Zhang Y., Leahy K., Hauser S., Masferrer J., Isakson P. Distribution of COX-1 and COX-2 in normal and inflamed tissues. Adv. Exp. Med. Biol. 1997, 400A:167-170.
3. Barrios-Rodiles M., Tiraloche G., Chadee K. Lipopolysaccharide modulates cyclooxygenase-2 transcriptionally and posttranscriptionally in human macrophages independently from endogenous IL-1 beta and TNF-alpha. J. Immunol. 1999, 163:963-969.
4. Chen Y., Zhang J., Moore S.A., Ballas Z.K., Portanova J.P., Krieg A.M., Berg D.J. CpG DNA induces cyclooxygenase-2 expression and prostaglandin production. Int. Immunol. 2001, 13:1013-1020.
5. Steiner A.A., Hunter J.C., Phipps S.M., Nucci T.B., Oliveira D.L., Roberts J.L., Scheck A.C., Simmons D.L., Romanovsky A.A. Cyclooxygenase-1 or -2-which one mediates lipopolysaccharide-induced hypothermia?. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 297:R485-R494.
6. Jaulmes A., Thierry S., Janvier B., Raymondjean M., Marechal V. Activation of sPLA2-IIA and PGE2 production by high mobility group protein B1 in vascular smooth muscle cells sensitized by IL-1beta. FASEB J. 2006, 20:1727-1729.
7. Williams T.J., Morley J. Prostaglandins as potentiators of increasedvascular permeability in inflammation. Nature 1973, 246:215-217.
8. Schleifer K.H., Kandler O. Peptidoglycan types of bacterial cell wallsand their taxonomic implications. Bacteriol. Rev. 1972, 36:407-477.
9. Chamaillard M., Hashimoto M., Horie Y., Masumoto J., Qiu S., Saab L., Ogura Y., Kawasaki A., Fukase K., Kusumoto S., Valvano M.A., Foster S.J., Mak T.W., Nunez G., Inohara N. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat. Immunol. 2003, 4:702-707.
10. Girardin S.E., Boneca I.G., Viala J., Chamaillard M., Labigne A., Thomas G., Philpott D.J., Sansonetti P.J. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 2003, 278:8869-8872.
11. Wicken A.J., Knox K.W. Lipoteichoic acids: a new class of bacterial antigen. Science 1975, 187:1161-1167.
12. Kimbrell M.R., Warshakoon H., Cromer J.R., Malladi S., Hood J.D., Balakrishna R., Scholdberg T.A., David S.A. Comparison of the immunostimulatory and proinflammatory activities of candidate Gram-positive endotoxins, lipoteichoic acid, peptidoglycan, and lipopeptides, in murine and human cells. Immunol. Lett. 2008, 118:132-141.
13. De Kimpe S.J., Kengatharan M., Thiemermann C., Vane J.R. The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:10359-10363.
14. Buckley J.M., Wang J.H., Redmond H.P. Cellular reprogramming by gram-positive bacterial components: a review. J. Leukoc. Biol. 2006, 80:731-741.
15. Thiemermann C. Interactions between lipoteichoic acid and peptidoglycan from Staphylococcus aureus: a structural and functional analysis. Microbes Infect. 2002, 4:927-935.
16. Kengatharan K.M., De Kimpe S., Robson C., Foster S.J., Thiemermann C. Mechanism of gram-positive shock: identification of peptidoglycan and lipoteichoic acid moieties essential in the induction of nitric oxide synthase, shock, and multiple organ failure. J. Exp. Med. 1998, 188:305-315.
17. Gao J.J., Xue Q., Zuvanich E.G., Haghi K.R., Morrison D.C. Commercial preparations of lipoteichoic acid contain endotoxin that contributes to activation of mouse macrophages invitro. Infect. Immun. 2001, 69:751-757.
18. Morath S., Geyer A., Spreitzer I., Hermann C., Hartung T. Structural decomposition and heterogeneity of commercial lipoteichoic acid preparations. Infect. Immun. 2002, 70:938-944.
19. Ryu Y.H., Baik J.E., Yang J.S., Kang S.S., Im J., Yun C.H., Kim D.W., Lee K., Chung D.K., Ju H.R., Han S.H. Differential immunostimulatory effects of Gram-positive bacteria due to their lipoteichoic acids. Int. Immunopharmacol. 2009, 9:127-133.
20. Jang K.S., Baik J.E., Han S.H., Chung D.K., Kim B.G. Multi-spectrometric analyses of lipoteichoic acids isolated from Lactobacillus plantarum. Biochem. Biophys. Res. Commun. 2011, 407:823-830.
21. Schroder N.W., Morath S., Alexander C., Hamann L., Hartung T., Zahringer U., Gobel U.B., Weber J.R., Schumann R.R. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J. Biol. Chem. 2003, 278:15587-15594.
22. Girardin S.E., Boneca I.G., Carneiro L.A., Antignac A., Jehanno M., Viala J., Tedin K., Taha M.K., Labigne A., Zahringer U., Coyle A.J., DiStefano P.S., Bertin J., Sansonetti P.J., Philpott D.J. Nod1 detects a unique muropeptide from Gram-negative bacterial peptidoglycan. Science 2003, 300:1584-1587.
23. Muller-Anstett M.A., Muller P., Albrecht T., Nega M., Wagener J., Gao Q., Kaesler S., Schaller M., Biedermann T., Gotz F. Staphylococcal peptidoglycan co-localizes with Nod2 and TLR2 and activates innate immune response via both receptors in primary murine keratinocytes. PLoS One 2010, 5:e13153.
24. Girardin S.E., Travassos L.H., Herve M., Blanot D., Boneca I.G., Philpott D.J., Sansonetti P.J., Mengin-Lecreulx D. Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J. Biol. Chem. 2003, 278:41702-41708.
25. Kang Y.J., Wingerd B.A., Arakawa T., Smith W.L. Cyclooxygenase-2 gene transcription in a macrophage model of inflammation. J. Immunol. 2006, 177:8111-8122.
26. Wang J.E., Dahle M.K., McDonald M., Foster S.J., Aasen A.O., Thiemermann C. Peptidoglycan and lipoteichoic acid in Gram-positive bacterial sepsis: receptors, signal transduction, biological effects, and synergism. Shock 2003, 20:402-414.
27. Annane D., Bellissant E., Cavaillon J.M. Septic shock. Lancet 2005, 365:63-78.
28. Morrison D.C., Ryan J.L. Endotoxins and disease mechanisms. Annu. Rev. Med. 1987, 38:417-432.
29. Bougarn S., Cunha P., Harmache A., Fromageau A., Gilbert F.B., Rainard P. Muramyl dipeptide synergizes with Staphylococcus aureus lipoteichoic acid to recruit neutrophils in the mammary gland and to stimulate mammary epithelial cells. Clin. Vaccine Immunol. 2010, 17:1797-1809.
30. Kinsner A., Boveri M., Hareng L., Brown G.C., Coecke S., Hartung T., Bal-Price A. Highly purified lipoteichoic acid induced pro-inflammatory signalling in primary culture of rat microglia through Toll-like receptor 2: selective potentiation of nitric oxide production by muramyl dipeptide. J. Neurochem. 2006, 99:596-607.
31. Yang S., Tamai R., Akashi S., Takeuchi O., Akira S., Sugawara S., Takada H. Synergistic effect of muramyldipeptide with lipopolysaccharide or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture. Infect. Immun. 2001, 69:2045-2053.
32. Kim H.J., Yang J.S., Woo S.S., Kim S.K., Yun C.H., Kim K.K., Han S.H. Lipoteichoic acid and muramyl dipeptide synergistically induce maturation of human dendritic cells and concurrent expression of proinflammatory cytokines. J. Leukoc. Biol. 2007, 81:983-989.
33. Childs W.C., Neuhaus F.C. Biosynthesis of d-alanyl-lipoteichoic acid: characterization of ester-linked d-alanine in the invitro-synthesized product. J. Bacteriol. 1980, 143:293-301.
34. Deininger S., Stadelmaier A., von Aulock S., Morath S., Schmidt R.R., Hartung T. Definition of structural prerequisites for lipoteichoic acid-inducible cytokine induction by synthetic derivatives. J. Immunol. 2003, 170:4134-4138.
35. Chen K., Zhang L., Huang J., Gong W., Dunlop N.M., Wang J.M. Cooperation between NOD2 and Toll-like receptor 2 ligands in theup-regulation of mouse mFPR2, a G-protein-coupled Abeta42 peptide receptor, in microglial cells. J. Leukoc. Biol. 2008, 83:1467-1475.
36. Jeon D.I., Park S.R., Ahn M.Y., Ahn S.G., Park J.H., Yoon J.H. NOD1and NOD2 stimulation triggers innate immune responses ofhuman periodontal ligament cells. Int. J. Mol. Med. 2012, 29:699-703.
37. Keller J.F., Carrouel F., Staquet M.J., Kufer T.A., Baudouin C., Msika P., Bleicher F., Farges J.C. Expression of NOD2 is increased in inflamed human dental pulps and lipoteichoic acid-stimulated odontoblast-like cells. Innate Immun. 2011, 17:29-34.
38. Borm M.E., van Bodegraven A.A., Mulder C.J., Kraal G., Bouma G. The effect of NOD2 activation on TLR2-mediated cytokine responses is dependent on activation dose and NOD2 genotype. Genes Immun. 2008, 9:274-278.
39. Seo H.S., Michalek S.M., Nahm M.H. Lipoteichoic acid is important in innate immune responses to Gram-positive bacteria. Infect. Immun. 2008, 76:206-213.
40. Volz T., Nega M., Buschmann J., Kaesler S., Guenova E., Peschel A., Rocken M., Gotz F., Biedermann T. Natural Staphylococcus aureus-derived peptidoglycan fragments activate NOD2 and act as potent costimulators of the innate immune system exclusively in the presence of TLR signals. FASEB J. 2010, 24:4089-4102.